The risk score strongly correlated with the expression of VEGFA, VEGFB, CD276 and C10orf54 (Figure 8C), and each immune checkpoint was differentially expressed between normal and tumour samples (Figure 8D). This evidence concerns the gene VEGFB and neoplasm.